Identification of potential therapeutic target SPP1 and related RNA regulatory pathway in keloid based on

Ruxin Xie1, Jiao Yun1, Chenyu Li1

  • 1Department of Burn and Plastic Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

Annals of Medicine
|July 23, 2024
PubMed
Abstract

Insights

This study identified SPP1 as a potential biomarker for keloid. The NEAT1/miR-181a-5p/SPP1 pathway may regulate keloid formation, offering new therapeutic targets for this condition.

Area of Science:

  • Dermatology and Molecular Biology
  • Bioinformatics and Genomics

Background:

  • Keloid recurrence rates remain high with conventional treatments.
  • Understanding keloid pathogenesis requires novel biomarker and mechanism identification.

Purpose of the Study:

  • To identify novel biomarkers and molecular mechanisms underlying keloid progression using bioinformatics.
  • To explore potential therapeutic targets for keloid treatment.

Main Methods:

  • Downloaded and analyzed microarray datasets from the GEO database for keloid.
  • Utilized R software to identify differentially expressed genes (DEGs).
  • Employed bioinformatics tools to identify hub genes, predict upstream miRNAs and lncRNAs, and validated findings with RNA-sequencing and miRNA microarray.

Main Results:

  • Identified 31 DEGs, with SPP1 identified as a key upregulated hub gene.
  • Constructed a ceRNA network involving SPP1 (mRNA), miR-181a-5p (miRNA), and multiple lncRNAs (NEAT1, MALAT1, etc.).
  • Confirmed upregulation of miR-181a-5p and identified NEAT1 as a potential regulator of keloid progression.

Conclusions:

  • SPP1 is a potential candidate biomarker and therapeutic target for keloid.
  • The NEAT1/miR-181a-5p/SPP1 axis represents a potential RNA regulatory pathway in keloid formation.
  • Findings provide insights into keloid pathogenesis and suggest avenues for future therapeutic strategies.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K